Doctors Raise $30 Million for Cancer Treatment AI Startup
- Pi Health develops technology for oncology clinical trials
- Its platform connects drug makers with trials globally
This article is for subscribers only.
Pi Health, a startup that deploys artificial intelligence in the field of cancer treatment trials, raised more than $30 million in funding to further develop its technology and tie new partnerships.
AlleyCorp and Obvious Ventures led the Series A round, the Cambridge, Massachusetts-based startup said Thursday. The funding will launch Pi Health as an independent company, three years after it was incubated as a subsidiary of Nasdaq-listed BeiGene Ltd.